Patent eligibility Regulation of laboratory developed tests - discussion draft (no HR #) Diagnostic Accuracy and Innovation Act (DAIA) Section 216(a) of the Protecting Access to Medicare Act of 2014 (PAMA) (Pub. L. 113-
93) - payment and coding for laboratory tests
Billing rules for laboratory tests; date of service rule/14 day rule
CLFS CY2018 Preliminary Determinations
CPT - Copyright/Patent/Trademark MED - Medical/Disease Research/Clinical Labs MMM - Medicare/Medicaid
136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE 136 - Centers For Medicare and Medicaid Services (CMS) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 18 - Office of Management & Budget (OMB) 1 - SENATE
MYRIAD GENETIC LABORATORIES, INC.
1325 G Street NW, Suite 500, Washington, DC, 20005, US
KELLY NICKEL KIMBERLY LINTHICUM (Leg Director, Rep Bob Franks (1997-2000) Leg Correspondent, Rep Charles Taylor (1997) Leg Correspondent, Rep Bill Martini (1995-1996)) KELLY NICKEL KIMBERLY LINTHICUM (Leg Director, Rep Bob Franks (1997-2000) Leg Correspondent, Rep Charles Taylor (1997) Leg Correspondent, Rep Bill Martini (1995-1996)) KELLY NICKEL
Leg Director, Rep Bob Franks (1997-2000) Leg Correspondent, Rep Charles Taylor (1997) Leg Correspondent, Rep Bill Martini (1995-1996) Leg Director, Rep Bob Franks (1997-2000) Leg Correspondent, Rep Charles Taylor (1997) Leg Correspondent, Rep Bill Martini (1995-1996)